Litcius/Paper detail

Oncolytic herpesvirus therapy for mesothelioma – A phase I/IIa trial of intrapleural administration of HSV1716

Sarah Danson, Joe Conner, John Edwards, Kevin G. Blyth, P.M. Fisher, Munitta Muthana, Abdulazeez Salawu, Fiona Taylor, Elizabeth Hodgkinson, Patrick F. Joyce, Jennifer Roman, Kathleen Simpson, Alexander Graham, Kirsty Learmonth, Penella J. Woll

2020Lung Cancer56 citationsDOI

Topics & Concepts

MedicineTolerabilityClinical endpointOncolytic virusResponse Evaluation Criteria in Solid TumorsInternal medicineMesotheliomaAdverse effectChemotherapySurgeryOncologyProgressive diseaseClinical trialPathologyCancerVirus-based gene therapy researchCancer Research and TreatmentsOccupational and environmental lung diseases
Oncolytic herpesvirus therapy for mesothelioma – A phase I/IIa trial of intrapleural administration of HSV1716 | Litcius